Follow
Qing Zhang
Qing Zhang
University of Texas Health Science Center at San Antonio
Verified email at uthscsa.edu
Title
Cited by
Cited by
Year
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
AA Basiorka, KL McGraw, EA Eksioglu, X Chen, J Johnson, L Zhang, ...
Blood, The Journal of the American Society of Hematology 128 (25), 2960-2975, 2016
3252016
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study
NK Gillis, M Ball, Q Zhang, Z Ma, YL Zhao, SJ Yoder, ME Balasis, ...
The lancet oncology 18 (1), 112-121, 2017
2892017
A multi-institution phase I trial of ruxolitinib in patients with chronic myelomonocytic leukemia (CMML)
E Padron, A Dezern, M Andrade-Campos, K Vaddi, P Scherle, Q Zhang, ...
Clinical Cancer Research 22 (15), 3746-3754, 2016
1002016
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML
A Yoshimi, ME Balasis, A Vedder, K Feldman, Y Ma, H Zhang, SCW Lee, ...
Blood, The Journal of the American Society of Hematology 130 (4), 397-407, 2017
812017
Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis
C Talati, L Zhang, G Shaheen, A Kuykendall, M Ball, Q Zhang, JE Lancet, ...
Blood, The Journal of the American Society of Hematology 129 (13), 1881-1883, 2017
692017
Effects of nanoparticle size on antitumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studies
H Bao, Q Zhang, H Xu, Z Yan
International journal of nanomedicine, 929-940, 2016
622016
Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review
X Xu, L Zhang, Y Wang, Q Zhang, L Zhang, B Sun, Y Zhang
International journal of clinical and experimental pathology 6 (4), 788, 2013
552013
Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML
S Niyongere, N Lucas, JM Zhou, S Sansil, AD Pomicter, ME Balasis, ...
Leukemia 33 (1), 205-216, 2019
492019
BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt/β-catenin signalling
H Bao, Q Zhang, Z Zhu, H Xu, F Ding, M Wang, S Du, Y Du, Z Yan
Scientific reports 7 (1), 9153, 2017
402017
Anti-CD138 chimeric antigen receptor-modified T cell therapy for multiple myeloma with extensive extramedullary involvement
C Tian, H Yang, L Zhu, Q Zhang, Z Cao, Y Zhang
Annals of hematology 96, 1407-1410, 2017
282017
TP53 and IDH2 somatic mutations are associated with inferior overall survival after allogeneic hematopoietic cell transplantation for myelodysplastic syndrome
MA Kharfan-Dabaja, RS Komrokji, Q Zhang, A Kumar, A Tsalatsanis, ...
Clinical Lymphoma Myeloma and Leukemia 17 (11), 753-758, 2017
202017
Exogenous expression of WT1 gene influences U937 cell biological behaviors and activates MAPK and JAK-STAT signaling pathways
X Li, Y Li, T Yuan, Q Zhang, Y Jia, Q Li, L Huai, P Yu, Z Tian, K Tang, ...
Leukemia research 38 (8), 931-939, 2014
162014
The impact of camptothecin-encapsulated poly(lactic-co-glycolic acid) nanoparticles on the activity of cytochrome P450 in vitro
H Bao, Q Zhang, Z Yan
International journal of nanomedicine, 383-391, 2019
122019
Monitoring of WT1 and its target gene IRF8 expression in acute myeloid leukemia and their significance.
Q Zhang, Q Li, B Liu, Y Wang, D Lin, C Zhou, W Li, K Tang, Z Tian, ...
International journal of laboratory hematology 37 (4), 2015
122015
Apoptosis induction in K562 human myelogenous leukaemia cells is connected to the modulation of Wnt/β‐catenin signalling by BHX, a novel pyrazoline derivative
H Bao, Q Zhang, Y Du, C Zhang, H Xu, Z Zhu, Z Yan
Cell Proliferation 51 (3), e12433, 2018
102018
Pacritinib (PAC) synergistically potentiates azacitidine (5AZA) cytotoxicity in chronic myelomonocytic leukemia (CMML)
Y Ma, LR Rix, Q Zhang, ME Balasis, RS Komrokji, U Rix, AF List, ...
Blood 126 (23), 1658, 2015
82015
Expression of Kindlins and angiopoietins in acute myeloid leukemia
WB Wu, Q Zhang, Y Li, SL Shan, XY Li, Z Tian, KJ Tang, M Wang, Q Rao, ...
Zhongguo shi yan xue ye xue za zhi 20 (1), 7-11, 2012
72012
Regulation of HtrA2 on WT1 gene expression under imatinib stimulation and its effects on the cell biology of K562 cells
L Zhang, Y Li, X Li, Q Zhang, S Qiu, Q Zhang, M Wang, H Xing, Q Rao, ...
Oncology Letters 14 (3), 3862-3868, 2017
62017
SF3B1 mutations negatively predict for response to immunosuppressive therapy in myelodysplastic syndromes
Q Zhang, M Haider, NH Al Ali, JE Lancet, PK Epling-Burnette, AF List, ...
Clinical Lymphoma Myeloma and Leukemia 20 (6), 400-406. e2, 2020
52020
Somatic gene mutations serve as molecular biomarkers predictive for response to immunosuppressive therapy (IST) in myelodysplastic syndromes (MDS)
RS Komrokji, M Haider, NH Al Ali, JE Lancet, Q Zhang, ...
Blood 126 (23), 1664, 2015
52015
The system can't perform the operation now. Try again later.
Articles 1–20